Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › H3.3 CTL peptides and uses thereof

H3.3 CTL peptides and uses thereof

US Patent 10849965 · Granted Dec 1, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating EGFRvIII expressing glioblastomas2024
Methods of treating glioblastomas2024
H3.3 CTL peptides and uses thereof2024
H3.3 CTL peptides and uses thereof2024
Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor2024
Therapeutic agents comprising nucleic acids and TCR modified immune cells and us2023
Therapeutic compositions and applications that comprise nucleic acids and adopti2023
Peptide analogs capable of enhancing stimulation of a glioma-specific CTL respon2023
H3.3 CTL peptides and uses thereof2021
H3.3 CTL peptides and uses thereof2021
Methods for treating brain cancer using il-13r alpha 2 peptide-based composition2020
Method for treating brain tumors2020